CompletedPhase 2NCT00431119

Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

Studying Bullous pemphigoid

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital Muenster
Principal Investigator: Stefan Beissert, MD
Dermatology, Univ. of Muenster, Germany
Intervention: Azathioprine or Mycophenolate mofetil(drug)
Enrollment: 70 enrolled
Eligibility: 18-90 years · All sexes
Timeline: 1997 – 2000

Study locations (11)

Dermatology, Univ. of Cologne, Cologne, Germany
Dermatology, Univ. of Dresden, Dresden, Germany
Dermatology, Univ. of Duesseldorf, Düsseldorf, Germany
Dermatology, Univ. of Goettingen, Göttingen, Germany
Dermatology, Univ. Hospital Hannover, Hanover, Germany
Dermatology, Univ. of Kiel, Kiel, Germany
Dermatology, Univ. of Magdeburg, Magdeburg, Germany
Dermatology, Medical Faculty Mannheim, Univ. of Heidelberg, Mannheim, Germany
Dermatology, Municipal Hospital Minden, Minden, Germany
Dermatology, Univ. of Ulm, Ulm, Germany
Dermatology, Univ. of Wuerzburg, Würzburg, Germany

Collaborators

Hoffmann-La Roche

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00431119 on ClinicalTrials.gov

Other trials for Bullous pemphigoid

Additional recruiting or active studies for the same condition.

See all trials for Bullous pemphigoid →

← Back to all trials